Pharmafile Logo

News and Press Releases

Ofichem unifies brands under single CDMO and pharmaceutical supplier

One Ofichem. One voice. A more connected approach to pharmaceutical partnerships 8 April 2026 -- Ter Apel, the Netherlands -- Ofichem has brought its brands - Ofichem BV, Ofipharma, Ofimedicine,...

Category: Drug Delivery, Logistics, Manufacturing and Packing, Other
Posted: April 8, 2026

Ofichem
info@ofichem.com
Laboratorium Ofichem BV, Heembadweg 5, 9561 CZ Ter Apel The Netherlands

Samsung Biologics completes acquisition of GSK’s manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics’ geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: March 31, 2026

Samsung Biologics
300, Songdo bio-daero, Yeonsu-gu, Incheon, Republic of Korea

Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimisation

New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is designed to improve performance,...

Category: BioManufacturing, Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2026

Lonza
Muenchensteinerstrasse 38 Basel, 4002

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

• Reinforcing long-term commitment to embedding sustainability across operations and partnerships• Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide. 16 March 2026 -- Incheon, South Korea...

Category: BioManufacturing, Other, Pharmaceutical
Posted: March 16, 2026

Samsung Biologics
300, Songdo bio-daero, Yeonsu-gu, Incheon, Republic of Korea

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America

New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares’ leadership in biosimilars across...

Category: Biotechnology, Manufacturing and Packing, Other
Posted: March 10, 2026

SteinCares
general@steincares.com
San José, Escazú, Edificio Meridiano 5th floor, Costa Rica

kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics

Innovative glycobiology platform aimed at enhancing the efficacy, safety, and scalability of next-generation antibody therapeutics across multiple disease areas 9 March 2026 -- Paris, France -- kyron.bio, a biotechnology company pioneering...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 9, 2026

kyron.bio
hello@kyron.bio
Paris Biotech Santé-Site Cochin 27 rue du Faubourg Saint Jacques 75014 Paris, France

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline 9 March 2026...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 9, 2026

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California

24 February 2026 -- California, US -- Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 24, 2026

Avid Bioservices
14191 Myford Road Tustin, California 92780

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

European Commission grants approval for Gotenfia, a golimumab biosimilar to Simponi that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second...

Category: BioManufacturing, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 13, 2026

STADA
info@stada.de

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant

11 February 2026 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 11, 2026

Thermo Fisher Scientific
168 Third Avenue Waltham, MA 02451

Samsung Bioepis Reaches Settlement Agreement for Eylea (Aflibercept) Biosimilar in Europe and the Rest of the World

30 January 2026 -- Incheon, Korea -- Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Regeneron and Bayer concerning the commercialization of SB15, a biosimilar to...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026

Samsung Bioepis
76, Songdogyoyuk-ro, Yeonsu-gu, Incheon

Recipharm expands manufacturing to meet demanding FDA requirements

Established a new, dedicated non-bacterial beta-lactam manufacturing facility in response to FDA guidance Secured a strategic partnership with an innovative biopharma company seeking rapid regulatory compliance Developed a scalable platform...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 26, 2026

Recipharm

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

19 January 2026 -- Bengaluru, India -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 19, 2026

Syngene
Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099

Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference

Samsung Bioepis plans to secure 20 biosimilars in its products and pipeline by 2030 The new pipeline will include dupilumab, guselkumab, ixekizumab, fam-trastuzumab deruxtecan-nxki, vedolizumab, and ocrelizumab, in addition to...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 15, 2026

Samsung Bioepis
76, Songdogyoyuk-ro, Yeonsu-gu, Incheon

Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement

Initiative Focused on Scaling Advanced Cell and Gene Therapy to Enhance Patient Access 14 January 2026 -- Illinois, US -- Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced...

Category: BioManufacturing, Biotechnology, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 14, 2026

Fresenius Kabi
communications.USA@fresenius-kabi.com
Three Corporate Drive Lake Zurich, Illinois 60047